DK1025126T3 - Oprensning af molekyler - Google Patents

Oprensning af molekyler

Info

Publication number
DK1025126T3
DK1025126T3 DK98953320T DK98953320T DK1025126T3 DK 1025126 T3 DK1025126 T3 DK 1025126T3 DK 98953320 T DK98953320 T DK 98953320T DK 98953320 T DK98953320 T DK 98953320T DK 1025126 T3 DK1025126 T3 DK 1025126T3
Authority
DK
Denmark
Prior art keywords
contaminants
molecules
molecule
purification
column
Prior art date
Application number
DK98953320T
Other languages
Danish (da)
English (en)
Inventor
Robert L Fahrner
David Reifsnyder
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1025126T3 publication Critical patent/DK1025126T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK98953320T 1997-10-24 1998-10-08 Oprensning af molekyler DK1025126T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95776097A 1997-10-24 1997-10-24
PCT/US1998/021238 WO1999021889A1 (fr) 1997-10-24 1998-10-08 Purification de molecules

Publications (1)

Publication Number Publication Date
DK1025126T3 true DK1025126T3 (da) 2003-08-04

Family

ID=25500093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98953320T DK1025126T3 (da) 1997-10-24 1998-10-08 Oprensning af molekyler

Country Status (12)

Country Link
EP (1) EP1025126B1 (fr)
JP (1) JP4239131B2 (fr)
AT (1) ATE237636T1 (fr)
AU (1) AU740665B2 (fr)
CA (1) CA2306447C (fr)
DE (1) DE69813599T2 (fr)
DK (1) DK1025126T3 (fr)
ES (1) ES2195409T3 (fr)
IL (1) IL135087A (fr)
PT (1) PT1025126E (fr)
WO (1) WO1999021889A1 (fr)
ZA (1) ZA989424B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002316811A1 (en) 2001-06-28 2003-03-03 Novo Nordisk A/S Stable formulation of modified glp-1
EP1633391B1 (fr) 2003-06-03 2011-10-19 Novo Nordisk A/S Compositions peptidiques pharmaceutiques stabilisees
ATE541582T1 (de) 2003-06-03 2012-02-15 Novo Nordisk As Stabilisierte pharmazeutische glp-1 peptid zusammensetzungen
TR201906789T4 (tr) 2003-11-20 2019-05-21 Novo Nordisk As Üretim ve enjeksiyon cihazlarında kullanım için en uygun olan propilen glikol ihtiva eden peptit formülasyonları.
US8710181B2 (en) * 2004-08-31 2014-04-29 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
RU2413530C9 (ru) 2004-11-12 2021-05-18 Ново Нордиск А/С Стабильные препараты инсулинотропных пептидов
WO2007071768A1 (fr) 2005-12-23 2007-06-28 Novo Nordisk A/S Purification de proteines par chromatographie preparative en phase inverse (rpc)
CA2821711C (fr) 2010-12-15 2017-10-10 Baxter International Inc. Recuperation d'eluat par utilisation d'un gradient de conductivite
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1
CN116754678B (zh) * 2023-06-19 2025-09-16 杭州度安医学检验实验室有限公司 一种血液中胰岛素样生长因子检测样本的处理及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor

Also Published As

Publication number Publication date
EP1025126A1 (fr) 2000-08-09
PT1025126E (pt) 2003-09-30
AU740665B2 (en) 2001-11-08
JP2001521044A (ja) 2001-11-06
JP4239131B2 (ja) 2009-03-18
DE69813599T2 (de) 2004-04-08
EP1025126B1 (fr) 2003-04-16
ES2195409T3 (es) 2003-12-01
ATE237636T1 (de) 2003-05-15
CA2306447A1 (fr) 1999-05-06
WO1999021889A1 (fr) 1999-05-06
AU1072599A (en) 1999-05-17
CA2306447C (fr) 2009-04-07
DE69813599D1 (de) 2003-05-22
HK1031387A1 (en) 2001-06-15
ZA989424B (en) 2000-04-17
IL135087A (en) 2005-05-17

Similar Documents

Publication Publication Date Title
HU9602313D0 (en) Antibody purification
DK0906122T3 (da) Aktiverede linkers og fremgangsmåde til at fremstille og oprense disse
DK1025126T3 (da) Oprensning af molekyler
DE69417617D1 (de) Kolonne für Flüssigkeitschromatographie
DK1137663T3 (da) Oprensning af Echinocandin-cyclopeptidforbindelser
KR950700779A (ko) 단백질의 정제방법(Protein purification)
DK0703788T3 (da) Stabiliseret phenylalaninammoniaklyase
CY1107877T1 (el) Μεθοδος για το χρωματογραφικο καθαρισμο ινσουλινων
EP0626450A3 (fr) Protéines de fusion contenant l'enzyme conjugant l'ubiquitine (E2).
DK0833919T3 (da) Type F botulintoksin og anvendelse deraf
KR950701934A (ko) 소수성 폴리펩티드의 정제방법(purification method for hydrophobic polypeptide)
DE69706126D1 (de) Racemische Verbindung und diese enthaltende antiferroelektrische Flüssigkristallzusammensetzung
FI946031A7 (fi) Kringleä sisältävien proteiinien puhdistus ja etenkin t-PA:n
DK0920447T3 (da) Fremgangsmåde til rensning af cyclosporin
DE58902637D1 (de) Verfahren zum affinitaetschromatografischen reinigen von faktor xiii.
KR940005284A (ko) 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법
DE69738945D1 (de) Rken
DE69415664D1 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
IT9047695A0 (it) Analizzatore automatico in cromatografia liquida ad elevata risoluzione (hplc) per il trattamento e la purificazione dei campioni e per la determinazione di sostanze in essi contenute.
DE69422753D1 (de) Säulenpackung für Flüssigkeitschromatographie
ITRM930644A0 (it) Sublimatore per la purificazione di sostanze sensibili ai componenti atmosferici.